Smoking cessation medications do not appear to increase risk of neuropsychiatric side effects, study finds

Friday, April 22, 2016 - 21:30 in Health & Medicine

The smoking cessation medications varenicline and bupropion do not appear to increase the incidence of serious neuropsychiatric side effects compared to placebo, according to a new study.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net